This occurs because the medication's appetite-suppressing effects cease, and the body's natural hunger signals return to baseline levels
This is because you have more of the drug to clear from your system (but your side effects should still start decreasing after about one week)
[1] Retatrutide: What the Evidence Actually Shows Retatrutides pivotal obesity dataset is a Phase 2, double-blind, randomised, placebo-controlled trial in adults with obesity (or overweight plus a weight-related condition), testing once-weekly doses up to 12 mg over 48 weeks
This is where a consultation helps
Whether youre defining your pipeline strategy, evaluating launch scenarios, designing access models, or building long-term value across the obesity ecosystem, we bring the insights and rigor needed to lead
That's a reason to keep on top of your nutrition and strength-training while on these drugs, he writes, "especially for older people like me, who are [already] susceptible to muscle loss." There are people who should steer clear of GLP-1 drugs, Kessler notes, including those with a personal or familial history of certain thyroid and endocrine cancers, those with chronic kidney disease, pancreatitis, inflammatory bowel diseases, uncontrolled diarrhea or constipation or gastroparesis, or if you are pregnant
